D. E. Shaw & Co., Inc. Bristol Myers Squibb CO Call Options Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $6.7 Million - $8.82 Million	-166,500 Reduced 19.33%	694,700 $28.9 Million
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $48.6 Million - $55.1 Million	-1,013,200 Reduced 54.05%	861,200 $46.7 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $50.1 Million - $59.8 Million	-1,033,700 Reduced 35.55%	1,874,400 $96.2 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $22.7 Million - $25.4 Million	392,600 Added 15.61%	2,908,100 $169 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $16.8 Million - $18.7 Million	263,800 Added 11.72%	2,515,500 $161 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $15.2 Million - $17.2 Million	-231,200 Reduced 9.31%	2,251,700 $156 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $87.3 Million - $103 Million	1,274,800 Added 105.52%	2,482,900 $179 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $47,749 - $28.2 Million	-367,300 Reduced 23.31%	1,208,100 $85.9 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $30.2 Million - $33.3 Million	415,900 Added 35.87%	1,575,400 $121 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $23.9 Million - $28.7 Million	388,800 Added 50.45%	1,159,500 $84.7 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $32.9 Million - $38.3 Million	612,600 Added 387.48%	770,700 $48.1 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $2 Million - $2.34 Million	-33,800 Reduced 17.61%	158,100 $9.36 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $5.8 Million - $6.32 Million	93,700 Added 95.42%	191,900 $12.8 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $26.1 Million - $29.3 Million	-439,200 Reduced 81.73%	98,200 $6.2 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $10.3 Million - $11.6 Million	-177,600 Reduced 24.84%	537,400 $33.3 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $1.34 Million - $1.49 Million	23,400 Added 3.38%	715,000 $43.1 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $17.9 Million - $21 Million	-327,100 Reduced 32.11%	691,600 $40.7 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $1.63 Million - $2.37 Million	-35,200 Reduced 3.34%	1,018,700 $56.8 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $19.6 Million - $25.6 Million	399,300 Added 61.0%	1,053,900 $67.7 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $15.9 Million - $18.9 Million	372,800 Added 132.29%	654,600 $33.2 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $35 Million - $38.7 Million	-785,300 Reduced 73.59%	281,800 $12.8 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $35.3 Million - $42.1 Million	783,100 Added 275.74%	1,067,100 $50.9 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $4.83 Million - $6.26 Million	-99,000 Reduced 25.85%	284,000 $14.8 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $7.37 Million - $8.32 Million	133,600 Added 53.57%	383,000 $23.8 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $2.5 Million - $3.11 Million	49,400 Added 24.7%	249,400 $13.8 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $6.21 Million - $7.15 Million	-103,600 Reduced 34.12%	200,000 $12.7 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $17,982 - $19,605	300 Added 0.1%	303,600 $18.6 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $16.8 Million - $19.3 Million	303,300	303,300 $19.3 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.5 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.08 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.66 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.8 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.01 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account